section-viii

1 cases — ← All topics

Case Title Lower Court Docketed Status Flags Tags Question Presented
24A652 Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al. Federal Circuit 2024-12-31 Presumed Complete generic-drug hatch-waxman-act induced-infringement patent-infringement section-viii skinny-label Whether a generic drug manufacturer can be held liable for induced patent infringement when its label complies with the Hatch-Waxman Act's 'skinny lab…